Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The NIH announcement about its website transition and the use of “Super Intelligence” terminology is no longer displayed. The study page continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-08T13:30:21.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The record for a study of nivolumab and relatlimab in advanced microsatellite-stable colorectal cancer has been replaced by a 403 Forbidden error page, so the study details are unavailable.
    Difference
    20%
    Check dated 2026-11-01T14:38:04.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide notice announces a transition in NIH content from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:28:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-18T20:34:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T20:35:08.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating the study record is inaccessible. This change replaces the expected study content with the standard error view and related header/footer.
    Difference
    20%
    Check dated 2026-09-20T20:49:36.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.